Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
+167,166
New +$1.5M 0.02% 1350
2026
Q1
Sell
-12,871
Closed -$86.5K 4200
2025
Q4
$86.5K Sell
12,871
-119,332
-90% -$900K ﹤0.01% 2674
2025
Q3
$1.15M Buy
+132,203
New +$1.03M 0.06% 484
2025
Q2
Sell
-67,803
Closed -$435K 2922
2025
Q1
$435K Buy
+67,803
New +$560K 0.02% 1129
2024
Q4
Sell
-63,126
Closed -$797K 2733
2024
Q3
$797K Buy
63,126
+37,631
+148% +$486K 0.06% 531
2024
Q2
$323K Buy
+25,495
New +$256K 0.03% 909
2023
Q4
Sell
-42,063
Closed -$305K 1953
2023
Q3
$305K Buy
+42,063
New +$336K 0.05% 720
2023
Q2
Sell
-29,758
Closed -$206K 1706
2023
Q1
$206K Sell
29,758
-96,070
-76% -$884K 0.04% 941
2022
Q4
$1.29M Buy
125,828
+113,341
+908% +$2M 0.27% 47
2022
Q3
$227K Buy
12,487
+5,831
+88% +$253K 0.06% 703
2022
Q2
$342K Buy
+6,656
New +$345K 0.14% 229
2022
Q1
Sell
-2,220
Closed -$318K 875
2021
Q4
$318K Sell
2,220
-50
-2% -$8.59K 0.18% 183
2021
Q3
$471K Buy
+2,270
New +$500K 0.16% 206

Other funds holding NVAX

XTX Topco's NVAX Position: Q2 2026 in Review

XTX Topco opened a new position in Novavax (NVAX) in Q2 2026: 167,166 shares worth $1.57M. The stake represents 0.02% of the portfolio and ranks #1350 among its holdings. This is a return to the name: XTX Topco previously reported a position in NVAX as recently as Q4 2025.

XTX Topco first reported a position in NVAX in Q3 2021 and has held it in 13 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • XTX Topco held 167,166 shares of Novavax worth $1.57M as of Q2 2026.
  • Novavax was a new XTX Topco position in Q2 2026.
  • Novavax made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1350 holding.
  • XTX Topco first reported a position in Novavax in Q3 2021 and has held it in 13 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.